Conference Coverage

EADV: Family history of cardiovascular disease is key in psoriasis patients


 

AT THE EADV CONGRESS

References

An important caveat regarding this study, he continued, is that the mean age at which participants were diagnosed with psoriasis was 26.6 years. It’s unclear whether the study findings extend to individuals who develop the dermatologic disease later in life.

Dr. Egeberg reported having no financial conflicts regarding this study, supported by Danish national research funding.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Anti-TNF therapy can continue for IBD patients with skin lesions
MDedge Rheumatology
EADV: Pursuing ‘clear’ in psoriasis worthwhile, expert says
MDedge Rheumatology
Genetic differences may help predict progression of PsC to PsA
MDedge Rheumatology
Poor response to third anti-TNF agent seen in most psoriatic arthritis patients
MDedge Rheumatology
‘Cytokine converter’ cells alleviate psoriasis in mice
MDedge Rheumatology
Secukinumab cut ankylosing spondylitis symptoms in MEASURE trials
MDedge Rheumatology
More comorbidity with PsA form of spondyloarthritis
MDedge Rheumatology
Methotrexate has a role in treating articular manifestations of psoriatic arthritis
MDedge Rheumatology
ACR: Etanercept during pregnancy doubles the odds of major malformations
MDedge Rheumatology
EADV: New oral psoriasis drug shows excellent safety
MDedge Rheumatology